Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 591

1.

Racial differences in HPV type 16 prevalence in women with ASCUS of the uterine cervix.

Risley C, Clarke MA, Geisinger KR, Stewart MW, Zhang L, Hoover KW, Hiser LM, Owens K, DeMarco M, Schiffman M, Wentzensen N.

Cancer Cytopathol. 2020 Apr 3. doi: 10.1002/cncy.22267. [Epub ahead of print]

PMID:
32243726
2.

Challenges Associated With Cervical Cancer Screening and Management in Obese Women: A Provider Perspective.

Clarke MA, Massad LS, Khan MJ, Smith KM, Guido RS, Mayeaux EJ Jr, Darragh TM, Huh WK, Johnson AL, Gold MA, Schiffman M, Wentzensen N.

J Low Genit Tract Dis. 2020 Apr;24(2):184-191. doi: 10.1097/LGT.0000000000000506.

PMID:
32243314
3.

A Study of Partial Human Papillomavirus Genotyping in Support of the 2019 ASCCP Risk-Based Management Consensus Guidelines.

Demarco M, Egemen D, Raine-Bennett TR, Cheung LC, Befano B, Poitras NE, Lorey TS, Chen X, Gage JC, Castle PE, Wentzensen N, Perkins RB, Guido RS, Schiffman M.

J Low Genit Tract Dis. 2020 Apr;24(2):144-147. doi: 10.1097/LGT.0000000000000530.

PMID:
32243309
4.

Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines.

Egemen D, Cheung LC, Chen X, Demarco M, Perkins RB, Kinney W, Poitras N, Befano B, Locke A, Guido RS, Wiser AL, Gage JC, Katki HA, Wentzensen N, Castle PE, Schiffman M, Lorey TS.

J Low Genit Tract Dis. 2020 Apr;24(2):132-143. doi: 10.1097/LGT.0000000000000529.

PMID:
32243308
5.

2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.

Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, Huh WK, Kim JJ, Moscicki AB, Nayar R, Saraiya M, Sawaya GF, Wentzensen N, Schiffman M; 2019 ASCCP Risk-Based Management Consensus Guidelines Committee.

J Low Genit Tract Dis. 2020 Apr;24(2):102-131. doi: 10.1097/LGT.0000000000000525. No abstract available.

PMID:
32243307
6.

2019 ASCCP Risk-Based Management Consensus Guidelines: Methods for Risk Estimation, Recommended Management, and Validation.

Cheung LC, Egemen D, Chen X, Katki HA, Demarco M, Wiser AL, Perkins RB, Guido RS, Wentzensen N, Schiffman M.

J Low Genit Tract Dis. 2020 Apr;24(2):90-101. doi: 10.1097/LGT.0000000000000528.

PMID:
32243306
7.

An Introduction to the 2019 ASCCP Risk-Based Management Consensus Guidelines.

Schiffman M, Wentzensen N, Perkins RB, Guido RS.

J Low Genit Tract Dis. 2020 Apr;24(2):87-89. doi: 10.1097/LGT.0000000000000531. No abstract available.

PMID:
32243305
8.

Cervicovaginal microbiome and natural history of HPV in a longitudinal study.

Usyk M, Zolnik CP, Castle PE, Porras C, Herrero R, Gradissimo A, Gonzalez P, Safaeian M, Schiffman M, Burk RD; Costa Rica HPV Vaccine Trial (CVT) Group.

PLoS Pathog. 2020 Mar 26;16(3):e1008376. doi: 10.1371/journal.ppat.1008376. eCollection 2020 Mar.

9.

A study of the risks of CIN3+ detection after multiple rounds of HPV testing: Results of the 15-year cervical cancer screening experience at Kaiser Permanente Northern California.

Hammer A, Demarco M, Campos N, Befano B, Gravitt PE, Cheung L, Lorey TS, Poitras N, Kinney W, Wentzensen N, Castle PE, Schiffman M.

Int J Cancer. 2020 Mar 6. doi: 10.1002/ijc.32950. [Epub ahead of print]

PMID:
32141607
10.

Correction to: Low-cost HPV testing and the prevalence of cervical infection in asymptomatic populations in Guatemala.

Lou H, Gharzouzi E, Guerra SP, Fokom Domgue J, Sawitzke J, Villagran G, Garland L, Boland JF, Wagner S, Rosas H, Troxler J, McMillen H, Kessing B, Alvirez E, Castillo M, Morales H, Argueta V, Rosingh A, van Aerde-van Nunen FJHB, Lopez G, Pinedo HM, Schiffman M, Dean M, Orozco R.

BMC Cancer. 2020 Feb 28;20(1):164. doi: 10.1186/s12885-020-6672-3.

11.

Immune Response Following Quadrivalent Human Papillomavirus Vaccination in Women After Hematopoietic Allogeneic Stem Cell Transplant: A Nonrandomized Clinical Trial.

Stratton P, Battiwalla M, Tian X, Abdelazim S, Baird K, Barrett AJ, Cantilena CR, Childs RW, DeJesus J, Fitzhugh C, Fowler D, Gea-Banacloche J, Gress RE, Hickstein D, Hsieh M, Ito S, Kemp TJ, Khachikyan I, Merideth MA, Pavletic SZ, Quint W, Schiffman M, Scrivani C, Shanis D, Shenoy AG, Struijk L, Tisdale JF, Wagner S, Williams KM, Yu Q, Wood LV, Pinto LA.

JAMA Oncol. 2020 Feb 27. doi: 10.1001/jamaoncol.2019.6722. [Epub ahead of print]

PMID:
32105293
12.

Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: the CVT Trial.

Tsang SH, Sampson JN, Schussler J, Porras C, Wagner S, Boland J, Cortes B, Lowy DR, Schiller JT, Schiffman M, Kemp TJ, Rodriguez AC, Quint W, Gail MH, Pinto LA, Gonzalez P, Hildesheim A, Kreimer AR, Herrero R; Costa Rica HPV Vaccine Trial (CVT) Group.

J Natl Cancer Inst. 2020 Feb 24. pii: djaa010. doi: 10.1093/jnci/djaa010. [Epub ahead of print]

PMID:
32091596
13.

Evaluation of durability of a single-dose of the bivalent HPV vaccine: the CVT Trial.

Kreimer AR, Sampson JN, Porras C, Schiller JT, Kemp T, Herrero R, Wagner S, Boland J, Schussler J, Lowy DR, Chanock S, Roberson D, Sierra MS, Tsang SH, Schiffman M, Rodriguez AC, Cortes B, Gail MH, Hildesheim A, Gonzalez P, Pinto LA; Costa Rica HPV Vaccine Trial (CVT) Group.

J Natl Cancer Inst. 2020 Feb 24. pii: djaa011. doi: 10.1093/jnci/djaa011. [Epub ahead of print]

PMID:
32091594
14.

Mutations in the HPV16 genome induced by APOBEC3 are associated with viral clearance.

Zhu B, Xiao Y, Yeager M, Clifford G, Wentzensen N, Cullen M, Boland JF, Bass S, Steinberg MK, Raine-Bennett T, Lee D, Burk RD, Pinheiro M, Song L, Dean M, Nelson CW, Burdett L, Yu K, Roberson D, Lorey T, Franceschi S, Castle PE, Walker J, Zuna R, Schiffman M, Mirabello L.

Nat Commun. 2020 Feb 14;11(1):886. doi: 10.1038/s41467-020-14730-1.

15.

Identification of HPV genotypes causing cervical precancer using tissue-based genotyping.

Venetianer R, Clarke MA, van der Marel J, Tota J, Schiffman M, Dunn ST, Walker J, Zuna R, Quint W, Wentzensen N.

Int J Cancer. 2020 May 15;146(10):2836-2844. doi: 10.1002/ijc.32919. Epub 2020 Feb 22.

PMID:
32037535
16.

Incidental sonographic detection of bladder cancer in a woman with large uterine fibroids: significance and lessons learned.

Soliman MM, Cornman-Homonoff J, Schiffman MH.

Clin Imaging. 2020 May;61:1-3. doi: 10.1016/j.clinimag.2020.01.001. Epub 2020 Jan 7.

PMID:
31945687
17.

Relationships of p16 Immunohistochemistry and Other Biomarkers With Diagnoses of Cervical Abnormalities: Implications for LAST Terminology.

Castle PE, Adcock R, Cuzick J, Wentzensen N, Torrez-Martinez NE, Torres SM, Stoler MH, Ronnett BM, Joste NE, Darragh TM, Gravitt PE, Schiffman M, Hunt WC, Kinney WK, Wheeler CM; New Mexico HPV Pap Registry Steering Committee; p16 IHC Study Panel.

Arch Pathol Lab Med. 2019 Nov 13. doi: 10.5858/arpa.2019-0241-OA. [Epub ahead of print]

PMID:
31718233
18.

Efficacy of the AS04-adjuvanted HPV-16/18 vaccine: Pooled analysis of the Costa Rica Vaccine and PATRICIA randomized controlled trials.

Tota JE, Struyf F, Sampson JN, Gonzalez P, Ryser M, Herrero R, Schussler J, Karkada N, Rodriguez AC, Folschweiller N, Porras C, Schiffman M, Schiller JT, Quint W, Kreimer AR, Wheeler CM, Hildesheim A; Costa Rica Vaccine Trial ; PATRICIA study .

J Natl Cancer Inst. 2019 Nov 7. pii: djz222. doi: 10.1093/jnci/djz222. [Epub ahead of print]

PMID:
31697384
19.

Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer.

Sailer V, Eng KW, Zhang T, Bareja R, Pisapia DJ, Sigaras A, Bhinder B, Romanel A, Wilkes D, Sticca E, Cyrta J, Rao R, Sahota S, Pauli C, Beg S, Motanagh S, Kossai M, Fontunge J, Puca L, Rennert H, Zhaoying Xiang J, Greco N, Kim R, MacDonald TY, McNary T, Blattner-Johnson M, Schiffman MH, Faltas BM, Greenfield JP, Rickman D, Andreopoulou E, Holcomb K, Vahdat LT, Scherr DS, van Besien K, Barbieri CE, Robinson BD, Fine HA, Ocean AJ, Molina A, Shah MA, Nanus DM, Pan Q, Demichelis F, Tagawa ST, Song W, Mosquera JM, Sboner A, Rubin MA, Elemento O, Beltran H.

JCO Precis Oncol. 2019;3. doi: 10.1200/PO.19.00047. Epub 2019 Sep 20.

20.

Evaluation of TypeSeq, a Novel High-Throughput, Low-Cost, Next-Generation Sequencing-Based Assay for Detection of 51 Human Papillomavirus Genotypes.

Wagner S, Roberson D, Boland J, Kreimer AR, Yeager M, Cullen M, Mirabello L, Dunn ST, Walker J, Zuna R, Porras C, Cortes B, Sampson J, Herrero R, Rodriguez AC, Quint W, Van Doorn LJ; CVT Group , Hildesheim A, Schiffman M, Wentzensen N.

J Infect Dis. 2019 Oct 8;220(10):1609-1619. doi: 10.1093/infdis/jiz324.

21.

Experiences and psychological outcomes of the oocyte donor: a survey of donors post-donation from one center.

Blakemore JK, Voigt P, Schiffman MR, Lee S, Besser AG, Fino ME.

J Assist Reprod Genet. 2019 Oct;36(10):1999-2005. doi: 10.1007/s10815-019-01527-5. Epub 2019 Jul 13.

PMID:
31300913
22.

Viral coinfection analysis using a MinHash toolkit.

Dawson ET, Wagner S, Roberson D, Yeager M, Boland J, Garrison E, Chanock S, Schiffman M, Raine-Bennett T, Lorey T, Castle PE, Mirabello L, Durbin R.

BMC Bioinformatics. 2019 Jul 12;20(1):389. doi: 10.1186/s12859-019-2918-y.

23.

Inferior Mesenteric Arterial Supply to a Symptomatic Uterine Myoma.

Cornman-Homonoff J, Holcomb K, Schiffman MH.

J Minim Invasive Gynecol. 2020 Feb;27(2):248-249. doi: 10.1016/j.jmig.2019.07.003. Epub 2019 Jul 9. No abstract available.

PMID:
31299359
24.

Percutaneous drainage of an infected endometrioma.

Cornman-Homonoff J, Fenster TB, Schiffman MH.

Clin Imaging. 2019 Nov - Dec;58:105-107. doi: 10.1016/j.clinimag.2019.06.012. Epub 2019 Jun 22.

PMID:
31284177
25.

Response to Pretorius and Belinson.

Schiffman M, Hu L, Antani S, Wentzensen N.

J Natl Cancer Inst. 2020 Jan 1;112(1):115-116. doi: 10.1093/jnci/djz119. No abstract available.

PMID:
31187134
26.

Management of Recurrent Sigmoid Volvulus via Nontransmural Percutaneous Colon Fixation.

Cornman-Homonoff J, Milsom JW, Schiffman MH.

J Vasc Interv Radiol. 2019 Oct;30(10):1669-1671. doi: 10.1016/j.jvir.2019.01.028. Epub 2019 May 17. No abstract available.

PMID:
31109854
27.

Changes in DNA Level of Oncogenic Human Papillomaviruses Other Than Types 16 and 18 in Relation to Risk of Cervical Intraepithelial Neoplasia Grades 2 and 3.

Xi LF, Schiffman M, Hughes JP, Galloway DA, Koutsky LA, Kiviat NB.

Cancer Epidemiol Biomarkers Prev. 2019 Aug;28(8):1388-1394. doi: 10.1158/1055-9965.EPI-18-0802. Epub 2019 May 17.

PMID:
31101617
28.

Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program.

Wentzensen N, Clarke MA, Bremer R, Poitras N, Tokugawa D, Goldhoff PE, Castle PE, Schiffman M, Kingery JD, Grewal KK, Locke A, Kinney W, Lorey TS.

JAMA Intern Med. 2019 Jul 1;179(7):881-888. doi: 10.1001/jamainternmed.2019.0306. Erratum in: JAMA Intern Med. 2019 Jul 1;179(7):1007.

29.

False positive cervical HPV screening test results.

Schiffman M, de Sanjose S.

Papillomavirus Res. 2019 Jun;7:184-187. doi: 10.1016/j.pvr.2019.04.012. Epub 2019 Apr 25.

30.

Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotesting.

Landy R, Schiffman M, Sasieni PD, Cheung LC, Katki HA, Rydzak G, Wentzensen N, Poitras NE, Lorey T, Kinney WK, Castle PE.

Int J Cancer. 2020 Feb 1;146(3):617-626. doi: 10.1002/ijc.32268. Epub 2019 Apr 8.

31.

Development of the TypeSeq Assay for Detection of 51 Human Papillomavirus Genotypes by Next-Generation Sequencing.

Wagner S, Roberson D, Boland J, Yeager M, Cullen M, Mirabello L, Dunn ST, Walker J, Zuna R, Schiffman M, Wentzensen N.

J Clin Microbiol. 2019 Apr 26;57(5). pii: e01794-18. doi: 10.1128/JCM.01794-18. Print 2019 May.

32.

Human papillomavirus 16 sub-lineage dispersal and cervical cancer risk worldwide: Whole viral genome sequences from 7116 HPV16-positive women.

Clifford GM, Tenet V, Georges D, Alemany L, Pavón MA, Chen Z, Yeager M, Cullen M, Boland JF, Bass S, Steinberg M, Raine-Bennett T, Lorey T, Wentzensen N, Walker J, Zuna R, Schiffman M, Mirabello L.

Papillomavirus Res. 2019 Jun;7:67-74. doi: 10.1016/j.pvr.2019.02.001. Epub 2019 Feb 6.

33.

An Observational Study of Deep Learning and Automated Evaluation of Cervical Images for Cancer Screening.

Hu L, Bell D, Antani S, Xue Z, Yu K, Horning MP, Gachuhi N, Wilson B, Jaiswal MS, Befano B, Long LR, Herrero R, Einstein MH, Burk RD, Demarco M, Gage JC, Rodriguez AC, Wentzensen N, Schiffman M.

J Natl Cancer Inst. 2019 Sep 1;111(9):923-932. doi: 10.1093/jnci/djy225.

34.

Role of Screening History in Clinical Meaning and Optimal Management of Positive Cervical Screening Results.

Castle PE, Kinney WK, Xue X, Cheung LC, Gage JC, Poitras NE, Lorey TS, Katki HA, Wentzensen N, Schiffman M.

J Natl Cancer Inst. 2019 Aug 1;111(8):820-827. doi: 10.1093/jnci/djy192.

35.

Percutaneous Orthotopic IVC Construction in a Pediatric Patient with Symptomatic IVC Agenesis.

Schiffman MH, Cornman-Homonoff J, Sos TA.

Cardiovasc Intervent Radiol. 2019 Feb;42(2):308-312. doi: 10.1007/s00270-018-2098-6. Epub 2018 Nov 12.

PMID:
30420997
36.

Niche adaptation and viral transmission of human papillomaviruses from archaic hominins to modern humans.

Chen Z, DeSalle R, Schiffman M, Herrero R, Wood CE, Ruiz JC, Clifford GM, Chan PKS, Burk RD.

PLoS Pathog. 2018 Nov 1;14(11):e1007352. doi: 10.1371/journal.ppat.1007352. eCollection 2018 Nov.

37.

Cytologic patterns of cervical adenocarcinomas with emphasis on factors associated with underdiagnosis.

Conrad RD, Liu AH, Wentzensen N, Zhang RR, Dunn ST, Wang SS, Schiffman M, Gold MA, Walker JL, Zuna RE.

Cancer Cytopathol. 2018 Nov;126(11):950-958. doi: 10.1002/cncy.22055. Epub 2018 Oct 23.

38.

Five-Year Risk of Cervical Precancer Following p16/Ki-67 Dual-Stain Triage of HPV-Positive Women.

Clarke MA, Cheung LC, Castle PE, Schiffman M, Tokugawa D, Poitras N, Lorey T, Kinney W, Wentzensen N.

JAMA Oncol. 2019 Feb 1;5(2):181-186. doi: 10.1001/jamaoncol.2018.4270.

39.

Impact of human papillomavirus vaccination on the clinical meaning of cervical screening results.

Castle PE, Xie X, Xue X, Poitras NE, Lorey TS, Kinney WK, Wentzensen N, Strickler HD, Burger EA, Schiffman M.

Prev Med. 2019 Jan;118:44-50. doi: 10.1016/j.ypmed.2018.10.001. Epub 2018 Oct 11.

PMID:
30316878
40.

The next generation of cervical cancer screening programs: Making the case for risk-based guidelines.

Perkins RB, Schiffman M, Guido RS.

Curr Probl Cancer. 2018 Sep;42(5):521-526. doi: 10.1016/j.currproblcancer.2018.06.007. Epub 2018 Jun 25. No abstract available.

PMID:
30146347
41.

Quality Improvement to Demonstrate the Lack of Reliability of the Human Papillomavirus mRNA Assay to Identify Women With Latent Human Papillomavirus Infections.

Schiffman M, Huh WK, Stockdale CK, Einstein MH, Chelmow D, Flowers LC.

Obstet Gynecol. 2018 Sep;132(3):778-779. doi: 10.1097/AOG.0000000000002828. No abstract available.

42.

Risk of Cervical Intraepithelial Neoplasia 2 or Worse by Cytology, Human Papillomavirus 16/18, and Colposcopy Impression: A Systematic Review and Meta-analysis.

Silver MI, Andrews J, Cooper CK, Gage JC, Gold MA, Khan MJ, Massad LS, Parvu V, Perkins RB, Schiffman M, Smith KM, Wentzensen N.

Obstet Gynecol. 2018 Sep;132(3):725-735. doi: 10.1097/AOG.0000000000002812.

43.

How confident can we be in the current guidelines for exiting cervical screening?

Gravitt PE, Landy R, Schiffman M.

Prev Med. 2018 Sep;114:188-192. doi: 10.1016/j.ypmed.2018.07.005. Epub 2018 Jul 5.

PMID:
29981791
44.

Is It Time to Move Beyond Visual Inspection With Acetic Acid for Cervical Cancer Screening?

Silkensen SL, Schiffman M, Sahasrabuddhe V, Flanigan JS.

Glob Health Sci Pract. 2018 Jun 29;6(2):242-246. doi: 10.9745/GHSP-D-18-00206. Print 2018 Jun 27. No abstract available.

45.

Low-cost HPV testing and the prevalence of cervical infection in asymptomatic populations in Guatemala.

Lou H, Gharzouzi E, Guerra SP, Fokom Domgue J, Sawitzke J, Villagran G, Garland L, Boland JF, Wagner S, Rosas H, Troxler J, McMillen H, Kessing B, Alvirez E, Castillo M, Morales H, Argueta V, Rosingh A, van Aerde-van Nunen FJHB, Lopez G, Pinedo HM, Schiffman M, Dean M, Orozco R.

BMC Cancer. 2018 May 15;18(1):562. doi: 10.1186/s12885-018-4438-y. Erratum in: BMC Cancer. 2020 Feb 28;20(1):164.

46.

Risk of HPV-16/18 Infections and Associated Cervical Abnormalities in Women Seropositive for Naturally Acquired Antibodies: Pooled Analysis Based on Control Arms of Two Large Clinical Trials.

Safaeian M, Castellsagué X, Hildesheim A, Wacholder S, Schiffman MH, Bozonnat MC, Baril L, Rosillon D; Costa Rica HPV Vaccine Trial and the PATRICIA study groups.

J Infect Dis. 2018 Jun 5;218(1):84-94. doi: 10.1093/infdis/jiy112.

47.

Automated Cervical Screening and Triage, Based on HPV Testing and Computer-Interpreted Cytology.

Yu K, Hyun N, Fetterman B, Lorey T, Raine-Bennett TR, Zhang H, Stamps RE, Poitras NE, Wheeler W, Befano B, Gage JC, Castle PE, Wentzensen N, Schiffman M.

J Natl Cancer Inst. 2018 Nov 1;110(11):1222-1228. doi: 10.1093/jnci/djy044.

48.

Low Risk of Cervical Cancer/Precancer Among Most Women Under Surveillance Postcolposcopy.

Demarco M, Cheung LC, Kinney WK, Wentzensen N, Lorey TS, Fetterman B, Poitras NE, Befano B, Castle PE, Schiffman M.

J Low Genit Tract Dis. 2018 Apr;22(2):97-103. doi: 10.1097/LGT.0000000000000382.

49.

An Introduction to the New Journal Forum.

Perkins RB, Schiffman M, Foster DC.

J Low Genit Tract Dis. 2018 Apr;22(2):89-90. doi: 10.1097/LGT.0000000000000369. No abstract available.

PMID:
29570562
50.

Validation of a Human Papillomavirus (HPV) DNA Cervical Screening Test That Provides Expanded HPV Typing.

Demarco M, Carter-Pokras O, Hyun N, Castle PE, He X, Dallal CM, Chen J, Gage JC, Befano B, Fetterman B, Lorey T, Poitras N, Raine-Bennett TR, Wentzensen N, Schiffman M.

J Clin Microbiol. 2018 Apr 25;56(5). pii: e01910-17. doi: 10.1128/JCM.01910-17. Print 2018 May.

Supplemental Content

Loading ...
Support Center